PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Nov-2021 横河電機 革新的なバイオプロセス向けデジタルツイン技術をもつInsilico Biotechnologyを買収 Businesswire
02-Nov-2021 Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology Businesswire
02-Nov-2021 Novacyt S.A. ("Novacyt" or the "Company"): Validation of COVID-19 Tests in the UK under CTDA Legislation Businesswire
02-Nov-2021 Celyad Oncology Announces November 2021 Conference Schedule Businesswire
02-Nov-2021 Takeda se postuló para la selección de “mercado principal” y presentó el Informe de gobierno corporativo a la Bolsa de Valores de Tokio (Tokyo Stock Exchange, TSE), en línea con el Código de gobierno corporativo revisado y los documentos sobre ... Businesswire
02-Nov-2021 Nathan Jones, CEO von Xlear Inc., Erklärung als Reaktion auf eine Klage des Justizministeriums im Namen der Vereinigten Staaten, in der behauptet wird, dass bestimmte Aussagen von Xlear gegen das FTC-Gesetz und das Verbraucherschutzgesetz... Businesswire
02-Nov-2021 Compass Therapeutics Announces Pricing of Approximately $125 Million Public Offering of Common Stock and Uplisting to Nasdaq Capital Market Businesswire
02-Nov-2021 Declaração de Nathan Jones, CEO da Xlear, Inc. em resposta a um processo movido pelo Departamento de Justiça, em nome dos Estados Unidos, alegando que certas declarações feitas pela Xlear violaram a Lei FTC e a Lei de Proteção ao Consumidor Businesswire
02-Nov-2021 Déclaration de Nathan Jones, PDG de Xlear, Inc. en réponse à une action en justice déposée par le ministère de la Justice, au nom des États-Unis, alléguant que certaines déclarations faites par Xlear ont violé la loi FTC et la loi sur... Businesswire
01-Nov-2021 Fabrinet Announces First Quarter Fiscal Year 2022 Financial Results Businesswire
01-Nov-2021 Compass Therapeutics Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market Businesswire
01-Nov-2021 McKesson Reports Fiscal 2022 Second-Quarter Results Businesswire
01-Nov-2021 Compass Reports the Advancement of CTX-009, a Bispecific Antibody, to Phase 2a Development in Patients with Biliary Tract Cancers (BTC), and the Clearance of a Key Clinical Hurdle Businesswire
01-Nov-2021 MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Businesswire
01-Nov-2021 Alnylam Named a Science Magazine Top Employer for Third Consecutive Year Businesswire
01-Nov-2021 Legend Biotech Announces Extension of PDUFA Date for Cilta-Cel Businesswire
01-Nov-2021 Samenvatting: Takeda heeft de selectie van “Prime Market” aangevraagd, een verslag over corporate governance ingediend bij de Tokyo Stock Exchange (TSE) in overeenstemming met de herziene code voor corporate governance en documenten … Businesswire
01-Nov-2021 Riassunto: Takeda ha presentato domanda per la selezione nell’indice “Prime Market”, ha depositato la Relazione sul governo societario presso la Borsa di Tokyo (Tokyo Stock Exchange, TSE) in linea con la versione emendata del Codice di governo societario … Businesswire
01-Nov-2021 Keratoconjunctivitis Sicca (Dry Eye) Markets - Global Clinical Trials Review, H2 2021 - ResearchAndMarkets.com Businesswire
01-Nov-2021 Alec Salt and Jared Hartsock Join Turner Scientific, LLC Businesswire